重症筋無力症の疫学的予測（～2024）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 4
1.2 List of Figures 5

2 Introduction 6
2.1 Catalyst 6
2.2 Related Reports 7
2.3 Upcoming Reports 7

3 Epidemiology 8
3.1 Disease Background 8
3.2 Risk Factors and Comorbidities 8
3.3 Global Trends 10
3.4 Forecast Methodology 11
3.4.1 Sources Used 14
3.4.2 Sources Not Used 17
3.4.3 Forecast Assumptions and Methods 17
3.5 Epidemiological Forecast of Myasthenia Gravis (2014-2024) 21
3.5.1 Diagnosed Prevalent Cases of Myasthenia Gravis 21
3.5.2 Age-Specific Diagnosed PrevaIent Cases of Myasthenia Gravis 23
3.5.3 Sex-Specific Diagnosed Prevalent Cases of Myasthenia Gravis 24
3.5.4 Age-Standardized Diagnosed Prevalence of Myasthenia Gravis 26
3.5.5 Diagnosed Prevalent Cases of Myasthenia Gravis by MGFA Class 27
3.6 Discussion 28
3.6.1 Epidemiological Forecast Insight 28
3.6.2 Limitations of the Analysis 29
3.6.3 Strengths of the Analysis 29

4 Appendix 30
4.1 Bibliography 30
4.2 About the Authors 33
4.2.1 Epidemiologists 33
4.2.2 Reviewers 33
4.2.3 Global Director of Therapy Analysis and Epidemiology 34
4.2.4 Global Head of Healthcare 35
4.3 About GlobalData 35
4.4 About EpiCast 36
4.5 Disclaimer 36